Vaccine News

Vaccine news brought to you by Precision Vaccinations.

Dec 1, 2025 • 2:02 pm CST
Maps December 2025

The Republic of Indonesia and the World Health Organization (WHO) recently declared the end of its poliovirus type 2 outbreak, which was caused by years of low polio immunization coverage.

The outbreak began in October 2022, when the first confirmed case was reported in Aceh province. Over the next two years, polio cases appeared in the provinces of Banten, West Java, Central Java, East Java, North Maluku, Central Papua, Highland Papua, and South Papua.

The last confirmed case was in South Papua on June 27, 2024.

During the response, nearly 60 million additional doses of the polio vaccine were administered to children.

Indonesia's response included two rounds of nationwide polio campaigns using novel OPV-2 (nOPV2) vaccine between the end of 2022 and the third trimester of 2024.

In parallel, routine immunization coverage also improved, with the percentage of children receiving their second dose of inactivated polio vaccine (IPV) rising from 63% (1.9 million children) in 2023 to 73% (3.2 million children) in 2024.

"Indonesia's success marks a vital step towards a polio-free world. It also reinforces the entire WHO Western Pacific Region's ability to retain its polio-free status, an achievement we proudly reached  25 years ago," noted Dr Saia Ma'u Piukala, WHO Regional Director for the Western Pacific, in a press release on November 21, 2025.

"I urge all our 38 countries and areas to remain vigilant."

"One day, polio will be just a memory. Until then, we vaccinate."

As of late 2025, over 2 billion doses of the nOPV2 vaccine have been administered globally.

To highlight this risk to international travelers, the U.S. CDC updated its Level 2 - Practice Enhanced Precautions notice, which identifies 32 countries, and suggested IPV booster doses for certain people.

Dec 1, 2025 • 1:15 pm CST
US CDC December 2025

Over the last few decades, the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) has issued recommendations on vaccine use for the civilian population of the United States.

According to the draft agenda for the ACIP meeting posted on December 1, 2025, this Thursday's topics will include updates from the CDC, specifically regarding the Hepatitis B vaccine.

The ACIP includes up to 19 voting members who make vaccine recommendations selected by the Secretary of the U.S. Department of Health and Human Services.

The CDC says, 'The best way to prevent hepatitis B is by getting vaccinated.'

Then, on December 5, 2025, presentations of the ACIP Workgroups, CDC Vaccine Risk Monitoring Evaluation, Vaccine Schedule History, Childhood/Adolescent Immunization Schedule Discussion and Considerations.

Previous ACIP meeting agendas and presentations are posted on this CDC webpage.

Dec 1, 2025 • 9:29 am CST
US CDC November 2025

Recently, the World Health Organization stated that available data indicate that during 2024 and 2025, poliovirus has spread geographically alongside continued transmission within core reservoir areas in both polio-endemic countries.

To highlight this severe health risk, the U.S. CDC updated its Level 2 - Practice Enhanced Precautions notice, which now identifies 32 countries. 

This list includes Germany, Israel, and the United Kingdom.

The CDC statement issued on November 25, 2025, says that before traveling to any destination listed, adults who previously completed the entire routine polio vaccine series may receive a single, lifetime booster dose of polio vaccine.

When departing from the USA, polio vaccination services are offered at travel clinics and pharmacies.

Dec 1, 2025 • 8:55 am CST
US CDC 2025

The U.S. Centers for Disease Control and Prevention (CDC) recently issued a Travel Health Notice regarding the expanding health risk of contracting the rabies virus when visiting India. And the CDC reaffirmed the risk of fake rabies vaccinations.

On November 25, 2025, the CDC posted a Level 1 - Practice Usual Precautions notice stating a case of Rabies had been reported in the U.S. in a traveler from India. Travelers potentially exposed to Rabies in India should immediately seek local medical care.

This advice is essential as Rabies is a viral disease that affects the central nervous system. Last year, India's National Centre for Disease Control recorded 54 suspected rabies deaths.

The CDC says upon returning home, travelers should follow up with their health care provider as soon as possible. And in the USA, infected bats are the leading source of infection in people.

To prevent contracting rabies, travelers to India should avoid all contact with dogs, cats, and other wild mammals.

And consider getting vaccinated against Rabies before traveling abroad.

In the United States, rabies vaccines are available at pharmacies and travel clinics.

In India, the circulation of counterfeit ABHAYRAB human rabies vaccine has recently been reported in major cities. Counterfeit vaccines may not be effective in the prevention of Rabies and could contain harmful ingredients, says the CDC.

Nov 26, 2025 • 6:12 am CST
US CDC

Valneva SE today announced positive final results regarding the immunogenicity and safety from its Phase 2 study, VLA15-221, of the Lyme disease vaccine candidate, VLA15.

According to Valneva's press release on November 26, 2025, this study's findings demonstrated a strong anamnestic immune response and a favorable safety profile six months after the third booster dose (at month 48) across all age groups.

Furthermore, these results confirm that the vaccine is compatible with the expected benefits of annual vaccination before the start of each Lyme season, which coincides with increased outdoor activities in the Northeast and Midwest regions of the United States.

Juan Carlos Jaramillo, M.D., Chief Medical Officer of Valneva, commented in a press release. "Lyme disease continues to expand geographically and remains a pressing unmet medical need affecting communities across the Northern Hemisphere."

"Each set of positive results moves us closer to the possibility of making this vaccine available to adults, adolescents, and children living in Lyme-endemic areas."

This is very encouraging news as there are currently no approved human vaccines for Lyme disease, and VLA15 has advanced the furthest in clinical development.

Valneva partnered with Pfizer Inc. in April 2020 to develop and commercialize VLA15.

Nov 25, 2025 • 3:05 pm CST
Walgreens Respiratory Illness Index November 22, 2025

Launched in early November 2025, the Walgreens Acute Respiratory Index (ARI) for 2025-2026 tracks influenza and COVID-19 hotspots using prescription, testing, and over-the-counter product purchase data from its locations nationwide.

As of November 22, 2025, the District of Columbia, New York, Texas, and Michigan lead Walgreens' ARI index.

Nationwide, the overall ARI score was 2.5 out of 5.0.

Walgreens' unique digital tool offers a more comprehensive view of respiratory illness trends across the U.S., enabling the public, healthcare providers, and health officials to make more informed decisions throughout the respiratory virus season.

Rick Gates, Walgreens' chief pharmacy officer, commented in a press release, "Vaccination remains the safest and most effective way to prevent highly contagious illnesses like flu, RSV, and COVID-19."

Previously, the U.S. CDC FluView for Week 47 will be posted on November 21, 2025, stating 'seasonal influenza activity in the United States remains low nationally but is increasing.'

Various flu shots are offered throughout the influenza season at most community pharmacies.

Nov 25, 2025 • 12:41 pm CST
by Nimrod Oren

On the occasion of the Jubilee of the Poor, a special holy year which occurs once every 25 years, the European Centre for Disease Prevention and Control (ECDC) has been conducting enhanced monitoring through its epidemic intelligence activities. 

With multiple events that take place throughout the year and nning until December 2025, it is estimated that more than 35 million pilgrims will visit Rome during the Jubilee of the Poor.

As of November 21, 2025, the ECDC says the probability of EU/EEA citizens becoming infected with communicable diseases during the Jubilee 2025 is low if general preventive measures are followed, such as influenza vaccination according to national immunisation schedules.

 

Nov 25, 2025 • 7:49 am CST
Maps 2025

The Washington State Department of Health (WDOH) recently confirmed the death of an older adult from Grays Harbor County related to a specific type of 'bird flu.' The individual had underlying health conditions and was receiving treatment for an infection of the H5N5 avian influenza virus.

This report from WDOH, issued on November 21, 2025, marks the first human case of avian influenza A (H5N5) reported worldwide.

Washington Governor Bob Ferguson stated in a Facebook post, "My condolences to this individual's family and loved ones. Thank you to the dedicated medical professionals who cared for them, and to the public health experts working to monitor the situation and educate the public."

This person had a backyard flock of mixed domestic birds. DOH sampling identified avian influenza virus in the environment of the flock, making exposure to the domestic poultry, their environment, or wild birds the most likely source of exposure for this patient. People who had exposure to the backyard flock and its environment are also being monitored by local health authorities for symptoms.

The WDOG says the risk to the public remains low as no other people involved have tested positive for avian influenza.

Public health officials will continue to monitor anyone who was in close contact with the patient for symptoms to ensure that human-to-human spread has not occurred. There is no evidence of transmission of this virus between people.

From a prevention perspective, at least 20 H5 influenza vaccines are licensed worldwide.

As of November 25, 2025, U.S. FDA-approved avian influenza vaccines are not commercially available in the USA.

Nov 24, 2025 • 1:48 pm CST
Mexico Ministry of Health November 2025

The Pan American Health Organization (PAHO) recently announced that the entire Region of the Americas has lost its verification of endemic measles transmission elimination due to ongoing outbreaks in several countries.

For example, in early November, Canada lost its measles elimination status.

As of November 24, 2023, Mexico's Ministry of Health reported approximately 5,300 cumulative confirmed measles cases this year, primarily in the northern region, just south of New Mexico and Texas.

This data is comparable to Canada's, indicating that Mexico may also lose its measles-free status.

Meanwhile, the United States, located between Canada and Mexico, has reported around 1,753 measles cases this year, with a few ongoing outbreaks, particularly in northern South Carolina.

The standard recommendation shared among these countries and states is that most people should be fully vaccinated with the MMR vaccine to protect themselves from the easily transmissible virus.

Nov 23, 2025 • 1:30 pm CST
Maps November 23, 2025

The Maine CDC recently announced it was investigating a cluster of seven cases of shigellosis among residents of Cumberland, Kennebec, and Androscoggin counties. So far in 2025, there have been 22 cases, preliminary data as of November 19, 2025.

The Maine CDC says that in the past five years, the median number of annual shigellosis cases was 11.

Shigellosis is an acute enteric infection transmitted through the fecal-oral route, directly through person-to-person contact, including sexual contact, and indirectly through contaminated food, water, and other routes.

The World Health Organization says it is evaluating the role of vaccines against Shigella on antibiotic use. Although several candidate Shigella vaccines are being evaluated at different stages of preclinical and clinical development, currently, no licensed vaccines against Shigella diarrhoea are widely available.  

Nov 20, 2025 • 10:58 am CST
ECDC Nov. 20, 2025

The French health ministry today published an updated Bulletin summarizing the unusually high number of chikungunya virus cases this year.

As of November 20, 2025, there have been 87 locally acquired cases of chikungunya in France: 43 in the Gard and 44 in the Hérault, located along France's Mediterranean coast.

Additionally, France confirmed 1,052 imported cases, with about 72% related to travelers from the department of La Réunion, located in the southwest Indian Ocean.

Seperately, Italy has reported 384 local cases, with the largest cluster located in Carpi, San Prospero, Soliera, Novellara, Cavezzo, Modena, Nonantola, Correggio, Novi di Modena, and Cesenatico.

The reasons behind these outbreaks may be weather-related.

On November 17, 2025, the European CDC reported that, according to data in the scientific literature, the ambient temperature is one of the most important environmental factors influencing the mosquito-borne transmission of the chikungunya virus.

The optimal daily average temperature for chikungunya transmission by Ae. albopictus in temperate zones of the Northern Hemisphere is 24–26 °C.

However, transmission might occur within the temperature range of 12 – 30 °C.

Currently, the U.S. CDC advises travelers to these areas to speak with a healthcare provider about chikungunya vaccination options.

Nov 19, 2025 • 2:37 pm CST
ECDC Nov. 2025

The Chikungunya virus (CHIKV) has been circulating in the Region of the Americas for decades, causing large epidemics throughout the tropics and subtropics.

In the Federative Republic of Brazil, the co-circulation of arboviruses such as Dengue and Zika, and overlapping disease symptoms, CHIKV infection may be underdiagnosed, according to a recent study's findings.

Current data indicate that over 238,000 CHIKV cases and 115 related fatalities have been reported in Brazil this year.

In November 2025, the European CDC Situation Update reported CHIKV cases across all regions (Centro-Oeste, Nordeste, Norte, Sudeste, and Sul) and in most federal units of the country.

The Centro-Oeste and Sudeste regions account for the highest number of cases in recent weeks, where Mato Grosso Do Sul, Minas Gerais, and São Paulo are the most affected federal units in 2025.

The ECDC writes that cases are expected to increase from November onwards, based on observed trends in 2024 and 2023.

As of November 19, 2025, the U.S. CDC reports an elevated chikungunya risk in Brazil.

These health agency analyses are of interest to international travelers planning to attend Carnival 2026 in cities such as Rio de Janeiro.

The CDC says chikungunya vaccination may be considered for people traveling to or moving to this location if they plan to stay for an extended period. In the United States, approved chikungunya vaccination services are offered at travel clinics and pharmacies. 

Nov 18, 2025 • 11:46 am CST
Florida DOH November 2025

According to the Florida Department of Health (DOH), Arbovirus Surveillance Report, Week 46, travelers from Cuba have been diagnosed with various diseases in 2025.

As of November 15, 2025, the DOH reported 73 travel-related cases of chikungunya have been confirmed in Florida this year, with 62 related to Cuba.

In 2025, 355 cases of dengue fever were reported among individuals who had traveled internationally, with 252 cases among travelers from Cuba.

And one Oropouche case was reported in a traveler from Cuba in November.

According to the U.S. CDC, check the vaccines and medicines list and visit your healthcare provider at least a month before your trip to Cuba in 2025. Various travel vaccines are offered at clinics and pharmacies throughout the United States.

Nov 18, 2025 • 9:54 am CST
Maps 2025

 The U.S. Embassy in Kingston, Jamaica, recently issued an alert stating that Hurricane Melissa caused significant damage to the city of Montego Bay. Hurricane Melissa made landfall on October 28, 2025, causing widespread damage.

The Black River community was also heavily damaged.

As of November 14, 2025, the building that houses the U.S. Consular Agency in Montego Bay, Jamaica, sustained storm damage and power outages, and is closed until the building and office are determined to be safe for public access and utilities have been restored.

However, the U.S. Embassy in Kingston, Jamaica's capital city, and the U.S. Consular Agency in The Cayman Islands are open for routine and emergency consular services for U.S. citizens.

The current Level 3 Travel Advisory recommends considering rescheduling planned travel to Jamaica. If you plan to travel, confirm availability with your transportation provider and at your destination before you leave.

From a health perspective, the U.S. CDC writes that Healthcare professionals should ensure international travelers are up to date on travel vaccines and medications, as well as prepared to manage their health before visiting Jamaica.

And local media reported in November 2025 that various cities are offering free vaccine clinics providing free vaccines for flu, COVID, and routine childhood vaccines, accessible from local pharmacies.

 

Nov 18, 2025 • 4:50 am CST
Maps 2025

The Global Polio Eradication Initiative (GPEI) today reported vaccine-derived poliovirus type 2 (VDPV2) has been detected in an environmental sewage sample collected in Yorkshire and the Humber, in northern England, home to about 5.6 million people.

As of September 16, 2025, the GPEi confirmed that this is the second VDPV2-positive environmental sample reported in the United Kingdom in 2025.

The GPEI says VDPV2 is a strain related to the weakened live poliovirus contained in the oral polio vaccine. If allowed to circulate in under- or unimmunized populations for long enough, or replicate in an immunodeficient individual, the weakened virus can revert to a form that causes illness and paralysis.

The U.S. CDC's Global Polio Travel Health Notice says that Most people with polio do not feel sick. Some people have only minor symptoms, such as fever, tiredness, nausea, headache, nasal congestion, sore throat, cough, stiffness in the neck and back, and pain in the arms and legs. In rare cases, polio infection causes permanent loss of muscle function.

The CDC did include the UK among the 39 countries identified in this Level 2 travel alert.

As of November 18, 2025, the CDC recommends that before traveling to any destination listed, adults who previously completed the complete, routine polio vaccine series may receive a single, lifetime booster dose of polio vaccine.

In the USA, the IPV vaccine is offered at clinics and travel pharmacies